The purpose of this study is:
- To compare blood sugar control on LY2605541 with insulin glargine after 52 weeks of
treatment.
- To compare the rate of night time low blood sugar episodes on LY2605541 with insulin
glargine during 52 weeks of treatment.
- To compare the number of participants on LY2605541 reaching blood sugar targets without
low blood sugar episodes at night to those taking insulin glargine after 52 weeks of
treatment.
- To compare the rate of low blood sugar episodes on LY2605541 with insulin glargine after
52 weeks of treatment